Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

NCT00087334 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Withdrawn due to poor/low accrual

Conditions

Colorectal Cancer

Interventions

DRUG: capecitabine
DRUG: gefitinib
DRUG: oxaliplatin

Sponsor

Roswell Park Cancer Institute